Wei M - Search Results

1

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.

Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. Li Z, et al. Among authors: wei m. Nat Commun. 2012 Feb 21;3:688. doi: 10.1038/ncomms1681. Nat Commun. 2012. PMID: 22353710 Free PMC article.

2

[Effects of acetylcholine on inositol 1,4,5-triphosphate formation in cervix uteri myometrial cells of human].

Nie H, Wei MJ, Gao MQ, Ding XP, Li Z. Nie H, et al. Among authors: wei mj. Zhongguo Yao Li Xue Bao. 1999 Jul;20(7):659-62. Zhongguo Yao Li Xue Bao. 1999. PMID: 10678135 Free article. Chinese.

3

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

Zhao L, Wang L, Jin F, Ma W, Ren J, Wen X, He M, Sun M, Tang H, Wei M. Zhao L, et al. Among authors: wei m. Breast Cancer Res Treat. 2009 Sep;117(2):253-9. doi: 10.1007/s10549-008-0192-1. Epub 2008 Sep 24. Breast Cancer Res Treat. 2009. PMID: 18814026

4

Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose.

He M, Zhao L, Wei MJ, Yao WF, Zhao HS, Chen FJ. He M, et al. Among authors: wei mj. Biol Pharm Bull. 2009 Jan;32(1):55-60. doi: 10.1248/bpb.32.55. Biol Pharm Bull. 2009. PMID: 19122281 Free article.

5

Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Zhao L, Yu Z, Li Y, Wen X, Ma W, Wang L, Ren J, Liu C, He M, Bai X, Sun M, Zheng Z, Mi X, Wang E, Olopade OI, Jin F, Wei M. Zhao L, et al. Among authors: wei m. Med Oncol. 2012 Sep;29(3):1569-75. doi: 10.1007/s12032-011-0107-6. Epub 2011 Nov 22. Med Oncol. 2012. PMID: 22105146

6

Reversing multidrug resistance by tyrosine kinase inhibitors.

He M, Wei MJ. He M, et al. Among authors: wei mj. Chin J Cancer. 2012 Mar;31(3):126-33. doi: 10.5732/cjc.011.10315. Epub 2012 Jan 9. Chin J Cancer. 2012. PMID: 22237041 Free PMC article. Review.

7

Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.

He M, Chen P, Arnovitz S, Li Y, Huang H, Neilly MB, Wei M, Rowley JD, Chen J, Li Z. He M, et al. Among authors: wei m. Blood Cells Mol Dis. 2012 Aug 15;49(2):102-6. doi: 10.1016/j.bcmd.2012.05.003. Epub 2012 May 25. Blood Cells Mol Dis. 2012. PMID: 22633751 Free PMC article.

8

Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.

Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M. Li Y, et al. Among authors: wei m. PLoS One. 2012;7(8):e44254. doi: 10.1371/journal.pone.0044254. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952942 Free PMC article.

9

[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].

He M, Liu MY, Wang S, Tang QS, Yao WF, Zhao HS, Wei MJ. He M, et al. Among authors: wei mj. Zhong Yao Cai. 2012 Oct;35(10):1641-4. Zhong Yao Cai. 2012. PMID: 23627134 Chinese.

10

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M. Jiao X, et al. Among authors: wei m. Breast Cancer Res Treat. 2013 Jun;139(3):717-30. doi: 10.1007/s10549-013-2607-x. Epub 2013 Jun 19. Breast Cancer Res Treat. 2013. PMID: 23780685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,788 results

Search Page

Filters